Public Health Webinar Series on Blood Disorders – Save the Date

Thalassemia Overview for Pediatricians—Thursday, November 7, 2024; 2:00–3:00 PM ET

The thalassemias are among the most common genetic disorders in the world; yet they exhibit a broad spectrum of phenotypes. Thalassemias can be subdivided based on the hemoglobin chain affected (alpha versus beta) and genotype, which roughly corresponds to severity level (major, minor, and intermedia). The thalassemia phenotypes can also be categorized into those that are transfusion-dependent (mostly thalassemia major) and those that are not (mostly thalassemia intermedia). Individuals born with severe forms require clinical management that may include chronic transfusion therapy and iron chelation. Early diagnosis of thalassemia results in optimal outcomes.

Thalassemia is typically managed by a hematologist; however, patients often present to pediatricians with symptoms, which lead to a diagnosis of thalassemia. In addition, it is important that pediatricians and hematologists discuss the management of a pediatric patient’s thalassemia and any impact that their condition may have upon other aspects of patient care that fall under the pediatrician’s purview.

In this webinar, Alexis Thompson, MD, MPH, will discuss the diagnosis and clinical management of thalassemia, with an emphasis on information that is most relevant for pediatricians. She will provide information on how to accurately diagnose thalassemia, as well as the pathophysiology and management most commonly associated with severe forms of thalassemia.

Learning Objectives:

1. List symptoms and markers commonly associated with a diagnosis of thalassemia.
2. List clinical manifestations and complications associated with thalassemia.
3. Describe the recommended monitoring and treatment plan for thalassemia.